An open-label study of olanzapine in the first episode of schizophrenia in adolescents

被引：0
作者：
Dabokowska, M [1 ]
机构：
[1] Med Acad, Dept Psychiat, Bydgoszcz, Poland
来源：
EUROPEAN PSYCHIATRY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：115S / 115S
页数：1
相关论文
共 50 条
  • [41] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Yasukawa, Rei
    Yasuda, Hideaki
    Hayashida, Maiko
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (05) : 287 - 292
  • [42] Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension
    Tohen, Mauricio
    Kryzhanovskaya, Ludmila
    Carlson, Gabrielle
    DelBello, Melissa
    Wozniak, Janet
    Kowatch, Robert
    Wagner, Karen
    Findling, Robert
    Lin, Daniel
    Robertson-Plouch, Carol
    Xu, Wen
    Dittman, Ralf
    Biederman, Joe
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 882 - 882
  • [43] Long-term effectiveness and safety of blonanserin in patients with first-episode schizophrenia: A one-year open-label study
    Tenjin, T.
    Miyamoto, S.
    Ninomiya, Y.
    Miyake, N.
    Ogino, S.
    Harada, H.
    Yamashita, Y.
    Kaneda, Y.
    Sumiyoshi, T.
    Yamaguchi, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 110 - 110
  • [44] Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders
    Handen, Benjamin L.
    Hardan, Antonio Y.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2006, 45 (08) : 928 - 935
  • [45] AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA - REPLY
    OYEWUMI, LK
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1995, 20 (03): : 240 - 240
  • [46] Effects of Switching from Olanzapine to Aripiprazole on the Metabolic Profiles of Patients with Schizophrenia and Metabolic Syndrome: An Open-label Study
    不详
    INDIAN JOURNAL OF PSYCHIATRY, 2016, 58 (05) : S25 - S26
  • [47] Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 91S - 91S
  • [48] Olanzapine in the treatment of adolescents with bipolar mania; 26-week open-label extension
    Tohen, Mauricio
    Kryzhanovskaya, Ludmila
    Carlson, Gabrielle
    DelBello, Melissa
    Wozniak, Janet
    Kowatch, Robert
    Wagner, Karen
    Findling, Robert
    Lin, Daniel
    Robertson-Plouch, Carol
    Xu, Wen
    Dittmann, Ralf
    Biederman, Joe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S215 - S215
  • [49] Efficacy and tolerability of olanzapine in patients with schizophrenia in Lithuania: A 13-week, multicenter, open-label, nonrandomized study
    Maciulis, V
    Bitter, I
    Milasiunas, R
    Dembinskas, A
    Radavicius, L
    Kaunas, A
    Dossenbach, M
    Walker, D
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (01): : 57 - 69
  • [50] An open-label study of the treatment efficacy of olanzapine for Tourette's disorder
    Budman, CL
    Gayer, A
    Lesser, M
    Shi, QH
    Bruun, RD
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (04) : 290 - 294
12345